Organigram Global (OGI) Depreciation & Amortization (CF) (2018 - 2026)
Organigram Global (OGI) reported Depreciation & Amortization (CF) of $7.3 million for Q1 2026, up 116.51% year-over-year from $3.4 million in Q1 2025, and up 104.46% quarter-over-quarter from $3.6 million in Q4 2025.
Organigram Global (OGI) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $7.3 million in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $7.3 million, up 116.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $14.2 million (up 145.73% YoY), and the FY2025 annual result was $5.6 million, up 97.49% from the prior year.
- Depreciation & Amortization (CF) climbed to $7.3 million in Q1 2026 per OGI's latest filing, from $3.6 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $7.3 million in Q1 2026 and troughed at $2.4 million in Q4 2024.
- A 3-year average of $4.2 million and a median of $3.5 million in 2025 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2025 and 2026: Depreciation & Amortization (CF) soared 47.29% in 2025, then soared 116.51% in 2026.
- A 3-year view of Depreciation & Amortization (CF) shows it stood at $2.4 million in 2024, then soared by 47.29% to $3.6 million in 2025, then soared by 104.46% to $7.3 million in 2026.
- Business Quant data shows OGI's Depreciation & Amortization (CF) at $7.3 million in Q1 2026, $3.6 million in Q4 2025, and $3.4 million in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 21.95 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 22.68 Mn |
| 10 | Organigram Global | 731.20 Mn | 673.26 Mn | 11.96 Mn | 7.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.30 Mn |
| Mar 31, 2026 | 7.30 Mn |
| Dec 31, 2025 | 3.57 Mn |
| Dec 31, 2025 | 3.57 Mn |
| Mar 31, 2025 | 3.37 Mn |
| Mar 31, 2025 | 3.37 Mn |
| Dec 31, 2024 | 2.42 Mn |
| Dec 31, 2024 | 2.42 Mn |
| May 31, 2021 | 5.56 Mn |
| May 31, 2021 | 5.56 Mn |
| Feb 28, 2021 | 5.21 Mn |
| Feb 28, 2021 | 5.21 Mn |
| Nov 30, 2020 | 5.27 Mn |
| Nov 30, 2020 | 5.27 Mn |
| Aug 31, 2020 | -8.30 Mn |
| Aug 31, 2020 | -8.30 Mn |
| May 31, 2020 | 3.57 Mn |
| May 31, 2020 | 3.57 Mn |
| Feb 29, 2020 | 4.32 Mn |
| Feb 29, 2020 | 4.32 Mn |